Shiongi out-licenses COT-143 to AMR Centre - The Pharma Letter

Shiongi out-licenses COT-143 to AMR Centre  The Pharma Letter

Japanese drugmaker Shionogi (TYO: 4507) has entered into an out-licensing agreement on COT-143, a humanized monoclonal antibody targeting the PcrV ...



Comments

Popular posts from this blog

Rashes that look like scabies: Causes, symptoms, and treatment - Medical News Today

Urinary Tract Infection (UTI): Causes, Symptoms & Treatment - Cleveland Clinic

Symtuza: Uses, side effects, alternatives, and more - Medical News Today